Big Pharma actually allowing them to enter the market place on their own, would be shocking.
Big Pharma simply does not allow small bios to take market share.
But even more importantly, they don't want their own Big Pharma competitors taking market share. The risk of their Big Pharma competitors buying CYDY is worse then CYDY remaining an entity on it's own. They'll buy CYDY just so somebody else can't.